ARYx Licenses GenomeQuest Sequence Search Software
GenomeQuest, which offers sequence search technology for research and intellectual property applications, has announced that it is providing its GenomeQuest solution to ARYx Therapeutics, a privately held pharmaceutical company that specializes in retrometabolic drug design.
The solution enables biologists to evaluate gene sequences, and allows IP lawyers to research freedom to operate, patentability, and competitive landscape features for the same sequences.
The solution combines sequence search analytics with public and proprietary sequence content, including an indexed archive of close to 67 million patented sequences.
University of Aarhus to Use CLC Bio Combined Workbench
The Department of Molecular Biology at Denmark’s University of Aarhus has signed a site license agreement for CLC Bio's bioinformatics software solution, CLC Combined Workbench. The offering will be rendered in tandem with CLC’s “Educational Package,” which offers a backbone of bioinformatics courses.
The deal runs for five years and is for several hundred seats.
CLC Combined Workbench is a software solution for DNA, RNA, and protein analyses, containing all features of the company’s CLC Free Workbench, CLC Protein Workbench, and CLC Gene Workbench in an integrated software package. The software is available for Mac OS X, Windows, and Linux platforms, including Windows Vista and the upcoming Mac OS X 10.5 "Leopard."
Mitsubishi Pharma Opts for BioWisdom’s KnowledgeScan
Mitsubishi Pharma has signed an agreement for Biowisdom’s KnowledgeScan service.
The agreement follows on the heels of a similar deal the company announced last week with GlaxoSmithKline [BioInform 06-01-07].
Based on Biowisdom’s Sofia platform, the KnowledgeScan service provides intelligence reports for healthcare-related decision making.
GeneGo Licenses GVK Biosciences’ Medicinal Chemistry Database
GVK Biosciences said this week that it has licensed its Medicinal Chemistry Database to GeneGo, a database provider that offers software and services to systems biologists.
GVK said that MCD includes 800,000 small molecule inhibitors and associated quantitative structure-activity relationship information manually extracted from more than 42,000 medicinal chemistry journal articles.
GeneGo said that it will integrate the MCD data with its MetaCore and MetaDrug products.